Ad
related to: ino stock pricesuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Inovio's net loss for the third quarter of 2024 was $25.2 million, or $0.89 per share, basic and dilutive, compared to a net loss of $33.9 million, or $1.52 per share, basic and dilutive, for the ...
Shares of vaccine researcher Inovio Pharmaceuticals (INO) are currently trading around the $15 level, and one analyst thinks that's a bargain. Oppenheimer analyst Hartaj Singh makes the argument ...
Inovio Pharmaceuticals (NASDAQ:INO) is heating up, as investors continue to flock to certain stocks for the novel coronavirus. Shares of INO stock have rallied 140% from the April 15 low to the ...
(See Inovio stock-price forecast on TipRanks)To find good ideas for biotech stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of ...
The World Health Organization (WHO) estimates there are approximately 70 potential vaccines for COVID-19 currently being developed across the globe. Inovio Pharmaceuticals’ (INO) INO-4800 is one ...
Inovio Pharmaceuticals, Inc. is an American biotechnology ... claiming it exaggerated evidence of its coronavirus vaccine's efficacy in order to boost its stock price ...
It’s been a thrilling year of ups and downs for Inovio (NASDAQ:INO). INO stock rocketed as much as 1,000% earlier this year following news that Inovio had a leading candidate in the race for a ...
A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock. Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today Skip to main ...
Ad
related to: ino stock pricesuperstockscreener.com has been visited by 10K+ users in the past month